Safety and Efficacy of Mitomycin C-based HIPEC After srHCC and PM of HCC

Clinical trial NCT05544253 · UNKNOWN

Trial details

NCT number: NCT05544253
Sponsor: West China Hospital
Status: UNKNOWN
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Hepatocellular Carcinoma Peritoneal Metastasis Hyperthymic HCC

Start date: 2022-10-01
Primary completion: 2024-09-01
Enrollment: 68

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.